Comparison of The Post-Extraction Dimensional Alterations Following Ridge Preservation Using Autogenous Partially and Completely Demineralized Dentin Grafts Versus Autogenous Whole-tooth Graft

November 9, 2026 updated by: Dina Osama Abdelwahab Megahed, Cairo University

Comparison of The Post-Extraction Dimensional Alterations Following Ridge Preservation Using Autogenous Partially and Completely Demineralized Dentin Grafts Versus Autogenous Whole-tooth Graft: A Randomized Controlled Clinical Trial

For alveolar ridge preservation after extraction of a non-restorable maxillary non-molar tooth, will the use of Autogenous partially or completely demineralized dentin grafts result in similar ridge dimensions compared to Autogenous whole-tooth graft?

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

One inevitable consequence of tooth loss is alveolar ridge resorption, which is progressive, irreversible, chronic, and cumulative. For implant placement, adequate dimensions of the alveolar ride housing are essential for proper implant positioning to provide for both implant stability and esthetics. Various procedures have been developed to limit post-extraction dimensional alterations or to restore normal bone dimensions, among which is ridge preservation. Numerous materials have been introduced and compared, nevertheless the best option is yet to be determined. Autogenous bone remains the gold standard for bone grafting, however one cannot ignore its unavoidable drawbacks, with donor site morbidity and the need for additional surgery having the biggest impact, as well as the limited amount that can be harvested and the unpredictable resorption rate. Several other options have been introduced with the aim of overcoming these disadvantages.

promising results have been reported, and the use of autogenous tooth bone graft (ATBG) is gaining popularity, since this material has a structure that closely resembles bone, especially the dentin which is composed of similar inorganic and organic elements, and also has osteoinductive and osteoconductive capacity.

Some studies using mineralized dentin matrix have shown that the material possesses excellent biocompatibility but is less effective than bone derived products in bone formation. On the other hand, several basic animal studies have shown that completely demineralized dentin matrix to be not only biocompatible, but also osteo-inductive, similar to demineralized bone matrix. The degree of demineralization is critical for optimal dentin regeneration; the partially demineralized dentin matrix is thought to have optimal conditions for dentin regeneration. Partial demineralization results in the elimination of the major part of the mineral phase and immunogenic components while retaining a very low fraction of minerals (5-10 wt%), providing an osteoconductive and osteo-inductive scaffold containing several growth factors.

It is agreed upon that nowadays optimizing protocols of demineralization of dentin grafts is necessary for standardization and further studies are required to determine the most suitable conditions of demineralization and particle sizes of dentin grafts for clinical application in implant dentistry. Additionally, more research is required to investigate whether graft preparation in its simplest form is sufficient or whether enhancing the graft with demineralization will result in any clinical significance.

Study Type

Interventional

Enrollment (Actual)

45

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt
        • Cairo University
      • Cairo, Egypt
        • Faculty of Dentistry, Cairo University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Individuals aged 18 years or older with no systemic health conditions

A single non-restorable tooth located in the maxillary esthetic region (between the first premolars)

Presence of a Type I extraction socket

Buccal bone plate remains intact after tooth extraction

Exclusion Criteria:

Any systemic condition known to impair bone healing (e.g., diabetes)

Use of drugs that influence bone metabolism (e.g., bisphosphonates)

Prior treatment with chemotherapy or radiotherapy

Active tobacco users

Presence of untreated periodontal disease

Inadequate oral hygiene, defined as plaque and bleeding scores exceeding 15%

Active endodontic infection at or near the extraction site

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Ridge preservation by filling the socket with autogenous partially demineralized dentin graft

2% HNO3 partial demineralization for 10 minutes

Socket preservation

Experimental: Ridge preservation by filling the socket with autogenous completely demineralized dentin graft

0.6N HCl for 30 minutes for complete demineralization

Socket preservation

Active Comparator: Ridge preservation by filling the socket with autogenous whole-tooth graft (AWTG).

After cleaning the tooth, it will be ground using bone mill and AWTG particles will be prepared by immersing tooth particles in basic ethanol for 10 min for disinfection , then washed twice in saline and dried using sterile gauze.

Socket preservation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Alveolar ridge width and height changes
Time Frame: After 4 months from alveolar ridge preservation

Difference in alveolar ridge width and height linear measurements in millimeters between baseline and final CBCT scans after 4 months

After 4 months from alveolar ridge preservation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Histological and Histomorphometric Analysis
Time Frame: 4 months after alveolar ridge preservation

Biopsies (n=9) will be collected and analyzed by a blinded pathologist. Tissue sections will be stained (H&E and Masson's Trichrome) to assess bone formation. ImageJ software will be used to quantify the percentage of new bone, residual graft, and soft tissue in standardized regions. Immunohistochemistry will assess expression of osteogenic proteins Osteopontin (OPN) and Dentin Matrix Protein-1 (DMP-1).

4 months after alveolar ridge preservation
Primary and Secondary Implant Stability
Time Frame: Measurements will be performed by a single calibrated and blinded examiner at two timepoints: immediately post-placement (primary stability) and after 2 months (secondary stability).

Implant stability will be evaluated using resonance frequency analysis (RFA) with the Osstell Beacon device (Osstell AB, Gothenburg, Sweden). A SmartPeg Type 05 will be attached to the implant, and RFA readings will be taken in bucco-palatal and mesio-distal directions with the probe held 2-4 mm from the SmartPeg at a 45° angle. The Implant Stability Quotient (ISQ; scale 0-100) will be recorded, and the mean of both directional values will be used for analysis.

Measurements will be performed by a single calibrated and blinded examiner at two timepoints: immediately post-placement (primary stability) and after 2 months (secondary stability).
Patient-reported pain score
Time Frame: Within the first postoperative week

Pain intensity will be measured using a 100-mm horizontal visual analogue scale (VAS), with endpoints labeled "No pain" (0) and "Worst imaginable pain" (10). Participants will mark the scale to indicate the maximum pain experienced during the first postoperative week. Pain scores will also be categorized as: No pain (0), Mild (1-3), Moderate (4-6), and Severe (7-10).

Within the first postoperative week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 10, 2023

Primary Completion (Actual)

August 15, 2024

Study Completion (Actual)

December 15, 2024

Study Registration Dates

First Submitted

February 14, 2023

First Submitted That Met QC Criteria

March 10, 2023

First Posted (Actual)

March 13, 2023

Study Record Updates

Last Update Posted (Actual)

November 12, 2026

Last Update Submitted That Met QC Criteria

November 9, 2026

Last Verified

January 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • DinaAbdelwahabPerio

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.